国药现代 (600420.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

CNY 11.33B

MomentumView details →

1D Return

−0.12%

YTD Return

−15.94%

RSI (14)

44.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.8x

Market Cap

CNY 11.33B

RSI (14)

44.0

MomentumView details →

1D Return

−0.12%

YTD Return

−15.94%

ProfitabilityView details →

Gross Margin

30.52%

Net Margin

8.15%

EBITDA Margin

23.09%

ROE (TTM)

5.16%

ROA (TTM)

3.69%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

−15.36%

EPS YoY

−35.48%

FCF YoY

−53.31%

Revenue CAGR 3Y

−10.27%

EPS CAGR 3Y

+4.72%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.59x

Quick Ratio

3.01x

Div Yield

3.53%

Div Rate

CNY 0.30

Div Growth 1Y

−33.33%

Financials snapshotView financials →

Revenue (TTM)

8.82B

Net Income (TTM)

718.59M

Op. CF (TTM)

1.03B

Latest newsMore news →

China National Medicines Corporation Ltd. received a drug registration certificate approved and issued by the National Medical Products Administration for Brexpiprazole tablets, an oral atypical antipsychotic drug for the treatment of adult schizophrenia, specification 2mg, registration classification as chemical drug category 4, deemed to have passed consistency evaluation.8d ago

China Resources Double Crane received a drug registration certificate from the National Medical Products Administration for lidocaine hydrochloride gel, which is deemed to have passed consistency evaluation.18d ago

Similar companies

微芯生物688321.SH Ab&B Bio Tech Co Ltd.02627.HK Consun Pharmaceutical Group Limited01681.HK 羚锐制药600285.SH 康恩贝600572.SH 国邦医药605507.SH Find similar companies →

Latest newsMore news →

China National Medicines Corporation Ltd. received a drug registration certificate approved and issued by the National Medical Products Administration for Brexpiprazole tablets, an oral atypical antipsychotic drug for the treatment of adult schizophrenia, specification 2mg, registration classification as chemical drug category 4, deemed to have passed consistency evaluation.8d ago China Resources Double Crane received a drug registration certificate from the National Medical Products Administration for lidocaine hydrochloride gel, which is deemed to have passed consistency evaluation.18d ago